{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:02:38Z","timestamp":1648911758925},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T00:00:00Z","timestamp":1361577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T00:00:00Z","timestamp":1361577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12029-013-9483-9","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T08:59:43Z","timestamp":1361523583000},"page":"91-95","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IgM Monoclonal Gammopathy in Gastric MALToma"],"prefix":"10.1007","volume":"45","author":[{"given":"Zhineng J.","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurprataap S.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth E.","family":"Fasanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounzer","family":"Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,23]]},"reference":[{"issue":"5","key":"9483_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361\u201392.","journal-title":"Blood"},{"issue":"4","key":"9483_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3816\/CLM.2005.n.003","volume":"5","author":"F Berger","year":"2005","unstructured":"Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, et al. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma. 2005;5(4):220\u20134.","journal-title":"Clin Lymphoma"},{"issue":"8580","key":"9483_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","volume":"1","author":"AG Stansfeld","year":"1988","unstructured":"Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, et al. Updated Kiel classification for lymphomas. Lancet. 1988;1(8580):292\u20133.","journal-title":"Lancet"},{"key":"9483_CR4","volume-title":"World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"E Jaffe","year":"2001","unstructured":"Jaffe E, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001."},{"issue":"2","key":"9483_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30(2):110\u20135.","journal-title":"Semin Oncol"},{"key":"9483_CR6","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SHCE Swerdlow","year":"2008","unstructured":"Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008."},{"issue":"19","key":"9483_CR7","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2008","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, The JES. WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2008;117(19):5019\u201332.","journal-title":"Blood"},{"issue":"7","key":"9483_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0145-2126(90)90016-3","volume":"14","author":"H Griesser","year":"1990","unstructured":"Griesser H, Kaiser U, Augener W, Tiemann M, Lennert K. B-cell lymphoma of the mucosa-associated lymphatic tissue (MALT) presenting with bone marrow and peripheral blood involvement. Leuk Res. 1990;14(7):617\u201322.","journal-title":"Leuk Res"},{"issue":"3","key":"9483_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.leu.2401206","volume":"13","author":"M Allez","year":"1999","unstructured":"Allez M, Mariette X, Linares G, Bertheau P, Jian R, Brouet JC. Low-grade MALT lymphoma mimicking Waldenstrom's macroglobulinemia. Leukemia. 1999;13(3):484\u20135.","journal-title":"Leukemia"},{"issue":"5","key":"9483_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1309\/6WPX-66CM-KGRH-V4RW","volume":"116","author":"R Valdez","year":"2001","unstructured":"Valdez R, Finn WG, Ross CW, Singleton TP, Tworek JA, Schnitzer B. Waldenstrom macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases. Am J Clin Pathol. 2001;116(5):683\u201390.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"9483_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3816\/CLM.2007.n.029","volume":"7","author":"V Salle","year":"2007","unstructured":"Salle V, Smail A, Joly JP, Capiod JC, Gontier MF, Duhaut P, et al. Gastric MALT lymphoma presenting as Waldenstrom's macroglobulinemia without bone marrow involvement. Clin Lymphoma Myeloma. 2007;7(7):470\u20131.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"21","key":"9483_CR12","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1158\/1078-0432.CCR-04-0803","volume":"10","author":"S Wohrer","year":"2004","unstructured":"Wohrer S, Streubel B, Bartsch R, Chott A, Raderer M. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res. 2004;10(21):7179\u201381.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"9483_CR13","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Schoder","year":"2005","unstructured":"Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005;23(21):4643\u201351.","journal-title":"J Clin Oncol"},{"issue":"3","key":"9483_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/annonc\/mdi093","volume":"16","author":"KP Beal","year":"2005","unstructured":"Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol. 2005;16(3):473\u201380.","journal-title":"Ann Oncol"},{"issue":"10","key":"9483_CR15","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1080\/10428190600733499","volume":"47","author":"L Alinari","year":"2006","unstructured":"Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2006;47(10):2096\u2013101.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"9483_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-0609.2007.00895.x","volume":"79","author":"C Perry","year":"2007","unstructured":"Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, et al. Diagnostic accuracy of PET\/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79(3):205\u20139.","journal-title":"Eur J Haematol"},{"issue":"4","key":"9483_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61(4):507\u201313.","journal-title":"Gut"},{"issue":"31","key":"9483_CR18","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T Wundisch","year":"2005","unstructured":"Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23(31):8018\u201324.","journal-title":"J Clin Oncol"},{"issue":"2","key":"9483_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7326\/0003-4819-131-2-199907200-00003","volume":"131","author":"G Steinbach","year":"1999","unstructured":"Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999;131(2):88\u201395.","journal-title":"Ann Intern Med"},{"issue":"17","key":"9483_CR20","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","volume":"16","author":"HS Park","year":"2010","unstructured":"Park HS, Kim YJ, Yang WI, Suh CO, Lee YC. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol. 2010;16(17):2158\u201362.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"9483_CR21","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"NR Schechter","year":"1998","unstructured":"Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16(5):1916\u201321.","journal-title":"J Clin Oncol"},{"issue":"4","key":"9483_CR22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0360-3016(01)02714-6","volume":"52","author":"S Hitchcock","year":"2002","unstructured":"Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM, et al. Treatment outcome of mucosa-associated lymphoid tissue\/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2002;52(4):1058\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"9483_CR23","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","volume":"21","author":"RW Tsang","year":"2003","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21(22):4157\u201364.","journal-title":"J Clin Oncol"},{"issue":"28","key":"9483_CR24","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96). J Clin Oncol. 2005;23(28):7050\u20139.","journal-title":"J Clin Oncol"},{"issue":"9","key":"9483_CR25","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23(9):1979\u201383.","journal-title":"J Clin Oncol"},{"issue":"10","key":"9483_CR26","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","volume":"13","author":"P Hammel","year":"1995","unstructured":"Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 1995;13(10):2524\u20139.","journal-title":"J Clin Oncol"},{"issue":"18","key":"9483_CR27","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","volume":"20","author":"G Jager","year":"2002","unstructured":"Jager G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20(18):3872\u20137.","journal-title":"J Clin Oncol"},{"issue":"22","key":"9483_CR28","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1002\/cncr.24605","volume":"115","author":"A Salar","year":"2009","unstructured":"Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, et al. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer. 2009;115(22):5210\u20137.","journal-title":"Cancer"},{"issue":"6","key":"9483_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2141.2009.07677.x","volume":"145","author":"JR Brown","year":"2009","unstructured":"Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P, et al. A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol. 2009;145(6):741\u20138.","journal-title":"Br J Haematol"},{"key":"9483_CR30","doi-asserted-by":"crossref","unstructured":"Zucca E, Conconi A, Martinelli G, Martelli M, Thieblemont C, Johnson PW, Lopez-Guillermo A, Bouabdallah R et al. (2010) Chlorambucil plus rituximab produces better event-free survival in comparison with chlorambucil alone in the treatment of MALT Lymphoma: 5-year analysis of the 2-arms part of the IELSG-19 randomized study. In: ASH Annual Meeting Abstracts. Orange County Convention Center, Orlando, 4\u20137 Dec 2010 116:432","DOI":"10.1182\/blood.V116.21.432.432"},{"issue":"3","key":"9483_CR31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdq416","volume":"22","author":"A Conconi","year":"2011","unstructured":"Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani PL, Ferreri AJ, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F, Zucca E. Clinical activity of bortezomib in relapsed\/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Ann Oncol 2011;22 (3):689\u2013695","journal-title":"Ann Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-013-9483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-013-9483-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-013-9483-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-013-9483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:34:58Z","timestamp":1628591698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-013-9483-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9483"],"URL":"https:\/\/doi.org\/10.1007\/s12029-013-9483-9","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,23]]},"assertion":[{"value":"23 February 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}